Pharmacy Society of Wisconsin
Registered Principal Details
Business Or Interest:
Pharmacy, heath care
Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy residents, pharmacy businesses, medication usage, medication costs, prescription drug use, medication use and abuse, and the practice of pharmacy.
CEO Name:
Sarah Sorum
Pharmacy, heath care
Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy residents, pharmacy businesses, medication usage, medication costs, prescription drug use, medication use and abuse, and the practice of pharmacy.
CEO Name:
Sarah Sorum
Contact
DMW
Danielle M Womack
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Forbes McIntosh | Exclusive Duties No | Authorized On 12/7/2022 | Withdrawn On N/A |
| Danielle M Womack | Exclusive Duties No | Authorized On 12/7/2022 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 143
Relating to: prohibiting statutes and rules examinations for certain professions. (FE)
Bill Text and History
4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: prohibiting statutes and rules examinations for certain professions. (FE)
Bill Text and History
For
Notification Date4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 144
Relating to: preliminary health care credentials granted to previously unlicensed individuals. (FE)
Bill Text and History
4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: preliminary health care credentials granted to previously unlicensed individuals. (FE)
Bill Text and History
For
Notification Date4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 176
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
5/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
For
Notification Date5/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 255
Relating to: creating a rural pharmacy practice grant program administered by the Higher Educational Aids Board, exempting from taxation amounts received from such a grant program, and granting rule-making authority.
Bill Text and History
6/6/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: creating a rural pharmacy practice grant program administered by the Higher Educational Aids Board, exempting from taxation amounts received from such a grant program, and granting rule-making authority.
Bill Text and History
For
Notification Date6/6/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 259
Relating to: 100-day prescription drug supplies under SeniorCare and amending an administrative rule related to 100-day prescription drug supplies permitted under SeniorCare. (FE)
Bill Text and History
9/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: 100-day prescription drug supplies under SeniorCare and amending an administrative rule related to 100-day prescription drug supplies permitted under SeniorCare. (FE)
Bill Text and History
For
Notification Date9/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 465
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.
Bill Text and History
10/25/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Supporting Documentation
10252023_092437_Statement on Professional Judgement.pdf
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.
Bill Text and History
Against
Notification Date10/25/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Supporting Documentation
10252023_092437_Statement on Professional Judgement.pdf
Assembly Bill 626
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
Bill Text and History
1/15/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
Bill Text and History
Against
Notification Date1/15/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 988
Relating to: eliminating minimum markup requirements and the prohibition on sales below cost. (FE)
Bill Text and History
1/26/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: eliminating minimum markup requirements and the prohibition on sales below cost. (FE)
Bill Text and History
Against
Notification Date1/26/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 158
Relating to: preliminary health care credentials granted to previously unlicensed individuals. (FE)
Bill Text and History
4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: preliminary health care credentials granted to previously unlicensed individuals. (FE)
Bill Text and History
For
Notification Date4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 160
Relating to: prohibiting statutes and rules examinations for certain professions. (FE)
Bill Text and History
4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: prohibiting statutes and rules examinations for certain professions. (FE)
Bill Text and History
For
Notification Date4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 211
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
For
Notification Date4/7/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 258
Relating to: creating a rural pharmacy practice grant program administered by the Higher Educational Aids Board, exempting from taxation amounts received from such a grant program, and granting rule-making authority.
Bill Text and History
5/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: creating a rural pharmacy practice grant program administered by the Higher Educational Aids Board, exempting from taxation amounts received from such a grant program, and granting rule-making authority.
Bill Text and History
For
Notification Date5/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 263
Relating to: 100-day prescription drug supplies under SeniorCare and amending an administrative rule related to 100-day prescription drug supplies permitted under SeniorCare. (FE)
Bill Text and History
2023 Wisconsin Act 71
9/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: 100-day prescription drug supplies under SeniorCare and amending an administrative rule related to 100-day prescription drug supplies permitted under SeniorCare. (FE)
Bill Text and History
2023 Wisconsin Act 71
For
Notification Date9/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 480
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.
Bill Text and History
10/25/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Supporting Documentation
10252023_092541_Statement on Professional Judgement.pdf
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.
Bill Text and History
Against
Notification Date10/25/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Supporting Documentation
10252023_092541_Statement on Professional Judgement.pdf
Senate Bill 705
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
Bill Text and History
1/15/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
Bill Text and History
Against
Notification Date1/15/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 737
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
12/5/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date12/5/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 888
Relating to: eliminating minimum markup requirements and the prohibition on sales below cost. (FE)
Bill Text and History
1/11/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: eliminating minimum markup requirements and the prohibition on sales below cost. (FE)
Bill Text and History
Against
Notification Date1/11/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
3/1/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
3/1/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide
Insurance: Departmentwide
Notification Date
3/1/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
3/1/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Departmentwide
Safety and Professional Services: Departmentwide
Notification Date
3/1/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
3/1/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Workforce Development: Departmentwide
Workforce Development: Departmentwide
Notification Date
3/1/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
3/1/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Administrative Rulemaking Proceedings
Agency Name
Pharmacy Examining Board (Phar)
Subject
Compounding pharmaceuticals
Scope Statement
SS 007_23
10/25/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Compounding pharmaceuticals
Scope Statement
SS 007_23
For
Notification Date10/25/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Registration of pharmacy technicians
Scope Statement
SS 052_22
3/2/2023
First Communication Date
3/2/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Pharmacy Examining Board (Phar)
Subject
Registration of pharmacy technicians
Scope Statement
SS 052_22
Other
Notification Date3/2/2023
First Communication Date
3/2/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Remote dispensing
Scope Statement
SS 053_22
3/2/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Remote dispensing
Scope Statement
SS 053_22
Other
Notification Date3/2/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Law examinations for pharmacist licensure
Law examinations for pharmacist licensure
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/31/2023
First Communication Date
3/29/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
3/31/2023
First Communication Date
3/29/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
Medical marijuana
Medical marijuana
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/31/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
3/31/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Drug importation
Drug importation
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/31/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
3/31/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Matters relating to pharmacist licensure
Matters relating to pharmacist licensure
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/2/2023
First Communication Date
2/22/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
3/2/2023
First Communication Date
2/22/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
Requirements relating to remote dispensing sites
Requirements relating to remote dispensing sites
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to scheduling of controlled substances
Matters related to scheduling of controlled substances
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacist reimbursement for services under MA
Pharmacist reimbursement for services under MA
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacy and pharmacist regulations
Pharmacy and pharmacist regulations
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacy Administrative Code
Pharmacy Administrative Code
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacy Benefit Managers
Pharmacy Benefit Managers
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters relating to pharmacy technician registration, education, and scope of practice
Matters relating to pharmacy technician registration, education, and scope of practice
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacist prescribing of contraception
Pharmacist prescribing of contraception
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
COVID-19
COVID-19
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/1/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2023 January - June |
2023 July - December |
2024 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2023 January - June $48,366.98 |
2023 July - December $34,255.92 |
2024 January - June $56,943.81 |
Total $139,566.71 |
| Total Hours Communicating | 2023 January - June 44.75 |
2023 July - December 68.25 |
2024 January - June 66.25 |
Total 179.25 |
| Total Hours Other | 2023 January - June 225.50 |
2023 July - December 223.75 |
2024 January - June 285.25 |
Total 734.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: preliminary health care credentials granted to previously unlicensed individuals. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 1% |
2023 July - December |
2024 January - June 2% |
2024 July - December |
Total 1% |
Relating to: preliminary health care credentials granted to previously unlicensed individuals. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 1% |
2023 July - December |
2024 January - June |
2024 July - December |
Total < 1% |
Relating to: creating a rural pharmacy practice grant program administered by the Higher Educational Aids Board, exempting from taxation amounts received from such a grant program, and granting rule-making authority.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 3% |
2023 July - December 2% |
2024 January - June 2% |
2024 July - December |
Total 2% |
Relating to: creating a rural pharmacy practice grant program administered by the Higher Educational Aids Board, exempting from taxation amounts received from such a grant program, and granting rule-making authority.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 3% |
2023 July - December 1% |
2024 January - June 2% |
2024 July - December |
Total 2% |
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 10% |
2023 July - December 10% |
2024 January - June |
2024 July - December |
Total 6% |
Relating to: prohibiting statutes and rules examinations for certain professions. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 10% |
2023 July - December 10% |
2024 January - June 10% |
2024 July - December |
Total 10% |
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 10% |
2023 July - December 10% |
2024 January - June 10% |
2024 July - December |
Total 10% |
Relating to: prohibiting statutes and rules examinations for certain professions. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 15% |
2023 July - December 10% |
2024 January - June 5% |
2024 July - December |
Total 10% |
Relating to: 100-day prescription drug supplies under SeniorCare and amending an administrative rule related to 100-day prescription drug supplies permitted under SeniorCare. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 1% |
2024 January - June |
2024 July - December |
Total < 1% |
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 1% |
2024 January - June |
2024 July - December |
Total < 1% |
Relating to: eliminating minimum markup requirements and the prohibition on sales below cost. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 1% |
2024 January - June 2% |
2024 July - December |
Total 1% |
Relating to: 100-day prescription drug supplies under SeniorCare and amending an administrative rule related to 100-day prescription drug supplies permitted under SeniorCare. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 2% |
2024 January - June |
2024 July - December |
Total < 1% |
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 2% |
2024 January - June |
2024 July - December |
Total < 1% |
Relating to: eliminating minimum markup requirements and the prohibition on sales below cost. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 2% |
2024 January - June 2% |
2024 July - December |
Total 1% |
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 10% |
2024 January - June 10% |
2024 July - December |
Total 7% |
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 10% |
2024 January - June 10% |
2024 July - December |
Total 7% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 15% |
2024 January - June 25% |
2024 July - December |
Total 14% |
Budget Bill Subjects
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 1% |
2023 July - December |
2024 January - June |
2024 July - December |
Total < 1% |
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 5% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 2% |
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 5% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 2% |
Administrative Rulemaking Proceedings
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 5% |
2023 July - December 5% |
2024 January - June 5% |
2024 July - December |
Total 5% |
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 10% |
2023 July - December 5% |
2024 January - June 5% |
2024 July - December |
Total 7% |
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 1% |
2024 January - June |
2024 July - December |
Total < 1% |
Topics Not Yet Assigned A Bill Or Rule Number
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 1% |
2023 July - December |
2024 January - June |
2024 July - December |
Total < 1% |
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 5% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 1% |
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 5% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 1% |
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 10% |
2023 July - December |
2024 January - June 10% |
2024 July - December |
Total 7% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.